Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc.
Company profile from EODHD, stored Oct 26, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 7, 2026 | $3.0K | -57.1% | 66.7% | -$702.0K | -$699.0K |
| Mar 2026filed May 12, 2026 | $7.0K | — | — | -$2.3M | -$2.3M |
| Dec 2025filed Mar 11, 2026 | $7.0K | — | -5,928.6% | -$1.2M | $5.2M |
| Sep 2025filed Nov 7, 2025 | $18.0K | — | 94.4% | -$948.0K | -$1.5M |
| Jun 2025filed Aug 14, 2025 | $7.0K | — | 85.7% | -$1.2M | -$14.3M |
| Mar 2025filed May 14, 2025 | — | — | — | -$1.0M | -$1.3M |
| Dec 2024filed Mar 28, 2025 | — | — | — | -$26.2M | -$27.1M |
| Sep 2024filed Nov 12, 2024 | — | — | — | -$1.1M | $4.2M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 11, 2026 | $32.0K | — | -1,225.0% | -$4.3M | -$11.8M |
| Dec 2024filed Mar 28, 2025 | — | — | — | — | — |
| Dec 2023filed Feb 20, 2024 | — | — | — | — | — |
| Dec 2022filed Dec 31, 2022 | $50.0K | 0.0% | — | -$3.4M | -$7.1M |
| Dec 2021filed Dec 31, 2021 | $50.0K | — | — | -$3.4M | -$7.1M |
| Dec 2020filed Dec 31, 2020 | — | — | — | -$896.7K | -$597.3K |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched IBO. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
26,292 shares short
-3,877 shares (-12.9%) vs Sep 30, 2026
2.9% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
30,169 shares short
A split falls between these reports; the share-count change is not compared.
3.3% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
526,986 shares short
-11,196 shares (-2.1%) vs Aug 31, 2026
4.6% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
538,182 shares short
-8,469 shares (-1.5%) vs Aug 14, 2026
4.7% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
546,651 shares short
-8,264 shares (-1.5%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
554,915 shares short
-2,489 shares (-0.4%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind IBO’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
79 for 1000 · reverse split
Effective Sep 23, 2026
Each 1000 pre-split shares become 79 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if IBO is in your portfolio and how much it contributes.
Sign inLoading market dates
3 smart-money holders: institutions with a high Holder IQ
Sentiment: bearish
Last trade: sell 44 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 11
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
21 filers reported a long position in IBO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
99.4%
of the 3.8M shares 13-F filers reported
Moves vs Q1 2026
2 added3 trimmed
2 new · 3 unchanged
Net shares held
+1.9%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | $545.6K · 1.2M shares | 1.2M | -0.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $372K · 808.7K shares | 808.7K | +14.2% |
| 3 | STATE STREET CORP | $279.6K · 607.9K shares | 607.9K | Unchanged |
| 4 | VANGUARD FIDUCIARY TRUST CO | $271.1K · 589.4K shares | 589.4K | +0.7% |
| 5 | BlackRock, Inc. | $119.6K · 259.9K shares | 259.9K | Unchanged |
| 6 | NORTHERN TRUST CORP | $108.3K · 235.5K shares | 235.5K | -3.5% |
| 7 | CITADEL ADVISORS LLC | $22.8K · 49.6K shares | 49.6K | New |
| 8 | Vanguard Global Advisers, LLC | $14.8K · 32.2K shares | 32.2K | Unchanged |
| 9 | JANE STREET GROUP, LLC | $11.3K · 24.5K shares | 24.5K | New |
| 10 | TWO SIGMA INVESTMENTS, LP | $7.9K · 17.2K shares | 17.2K | -54.1% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inUnlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.